$5.6B
Venture capital deployed to Health Management Solutions in 2025, capturing 18.8% of global share.
Key Insights
- Capital is Reacting to Systemic Failure: This is a structural market shift, not just a trend. Health Management Solutions captured $5.6 billion in venture funding in 2025, accounting for 18.8% of the global digital health share.
- The 4 Layers of the AI Health Management Stack: The modern stack is divided into Healthcare Operations & Workflow (capturing 49% of private ventures), Clinical Data Infrastructure (25%), Clinical Decision Intelligence (18%), and Patient Engagement (9%).
- Regional Procurement Strategies Diverge: The U.S. market rewards operational relevance and immediate ROI, with 49% of HMS funding directed toward Operations & Workflow. Europe operates on a fundamentally different profile; it is an evidence-led market governed by public tendering, where 47% of funding goes to Clinical Decision Intelligence.
- The Pilot Era is Ending: HMS partnerships declined by 25% from 846 in 2024 to 636 in 2025. This is a maturity signal, indicating that buyers are concentrating on fewer, deeper enterprise agreements that require multi-site deployment and documented ROI.
- Data Advantage is the New Competitive Moat: Real-world evidence (RWE) is rapidly replacing traditional clinical trials, resulting in a 43% decline in formal RCT volumes across all HMS categories. Simultaneously, regulatory approvals hit a peak of 324 in 2025.
Companies & Ventures Featured in the Report
Epic, Oracle Cerner, Innovaccer, Abridge, Elation, Aledade, HNI Healthcare, Qventus, Amalgam, OM1, Caresyntax, Nuna, Nex Health, Octagos Health, Mysphera, Nubimed, HeuristiK, Docline, IOMED, Recog, Smart Personal EHR, Fenomatch, Benshi.ai, and Iakan.
Why You Need This Report
- Health Systems: Discover how to scale AI from exploratory pilots to enterprise-wide deployments while aligning your workforce, procurement strategies, and EHR roadmaps.
- Investors: Understand why late-stage investment now requires significant capital and where the growth potential remains for AI-native solutions possessing regulatory clearance and platform scalability.
- Ventures: Learn why you must prove enterprise readiness through real-world ROI, deep workflow integrations (e.g., Epic/Oracle), and regulatory credibility in order to scale, acquire, or exit.
About the Data
Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform.
